I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Burris, Howard A.
355
results:
Search for persons
X
Format
Online (355)
Mediatypes
Articles (Online) (213)
OpenAccess-fulltext (142)
Sorted by: Relevance
Sorted by: Year
?
1
A phase I study of ATR inhibitor gartisertib (M4344) as a s..:
Burris, Howard A.
;
Berlin, Jordan
;
Arkenau, Tobias
...
British Journal of Cancer. 130 (2024) 7 - p. 1131-1140 , 2024
Link:
https://doi.org/10.1038/..
?
2
A risk analysis of alpelisib-induced hyperglycemia in patie..:
Rodón, Jordi
;
Demanse, David
;
Rugo, Hope S.
...
Breast Cancer Research. 26 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
3
P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B..:
Lech-Marańda, Ewa
;
Szymańska, Agata
;
Zaucha, Jan
...
HemaSphere. 7 (2023) S3 - p. e27994b8 , 2023
Link:
https://doi.org/10.1097/..
?
4
Plain Language Summary of the TOPAZ-1 Study: Durvalumab and..:
Oh, Do-Youn
;
He, Aiwu Ruth
;
Qin, Shukui
...
Future Oncology. 19 (2023) 34 - p. 2277-2289 , 2023
Link:
https://doi.org/10.2217/..
?
5
A real-world retrospective study of the use of Ki-67 testin..:
Brown, Jacqueline
;
Scardo, Savannah
;
Method, Michael
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
6
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:
Yap, Timothy A.
;
Gainor, Justin F.
;
Callahan, Margaret K.
...
Clinical Cancer Research. 28 (2022) 17 - p. 3695-3708 , 2022
Link:
https://doi.org/10.1158/..
?
7
Efficacy and safety of rucaparib treatment in patients with..:
Kristeleit, Rebecca S.
;
Drew, Yvette
;
Oza, Amit M.
...
British Journal of Cancer. 128 (2022) 2 - p. 255-265 , 2022
Link:
https://doi.org/10.1038/..
?
8
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Al..:
Lyou, Yung
;
Rosenberg, Jonathan E.
;
Hoffman-Censits, Jean
...
Clinical Genitourinary Cancer. 20 (2022) 1 - p. 35-42 , 2022
Link:
https://doi.org/10.1016/..
?
9
A Phase II Study Evaluating Orteronel, an Inhibitor of Andr..:
Yardley, Denise A.
;
Young, Robyn R.
;
Adelson, Kerin B.
...
Clinical Breast Cancer. 22 (2022) 3 - p. 269-278 , 2022
Link:
https://doi.org/10.1016/..
?
10
Characterization of patients with long-term responses to ru..:
Swisher, Elizabeth M.
;
Kristeleit, Rebecca S.
;
Oza, Amit M.
...
Gynecologic Oncology. 163 (2021) 3 - p. 490-497 , 2021
Link:
https://doi.org/10.1016/..
?
11
Safety and impact of dose reductions on efficacy in the ran..:
Burris, Howard A.
;
Chan, Arlene
;
Bardia, Aditya
...
British Journal of Cancer. 125 (2021) 5 - p. 679-686 , 2021
Link:
https://doi.org/10.1038/..
?
12
First-In-Human, First-In-Class, Phase I Trial of the Fucosy..:
Do, Khanh T.
;
Chow, Laura Quan Man
;
Reckamp, Karen
...
The Oncologist. 26 (2021) 11 - p. 925-e1918 , 2021
Link:
https://doi.org/10.1002/..
?
13
First-in-human study of the safety, pharmacokinetics, and p..:
Falchook, Gerald
;
Infante, Jeffrey
;
Arkenau, Hendrik-Tobias
...
EClinicalMedicine. 34 (2021) - p. 100797 , 2021
Link:
https://doi.org/10.1016/..
?
14
An open-label phase I dose-escalation study of the safety a..:
Liu, Joyce
;
Burris, Howard
;
Wang, Judy S.
...
Gynecologic Oncology. 163 (2021) 3 - p. 473-480 , 2021
Link:
https://doi.org/10.1016/..
?
15
A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib ..:
Weekes, Colin
;
Lockhart, Albert
;
LoRusso, Patricia
...
The Oncologist. 25 (2020) 10 - p. 833-e1438 , 2020
Link:
https://doi.org/10.1634/..
1-15